PD-L1 Status and Survival in Patients With Lung Cancer-Reply

JAMA. 2019 Aug 27;322(8):783-784. doi: 10.1001/jama.2019.9196.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Adenocarcinoma*
  • B7-H1 Antigen
  • Carcinoma, Non-Small-Cell Lung*
  • Genomics
  • Humans
  • Lung Neoplasms*

Substances

  • B7-H1 Antigen